Table 3.
Antibiotics prescribed to hospitalized patients (n = 2022)
| Antibiotic (ATC codes) | Frequency prescribed (N) | Percentage (%) |
|---|---|---|
| Penicillins | 283 | 14 |
| Narrow and broad spectrum | 120 | 42.4 |
| Ampicillin (J01CA01) | 14 | 0.7 |
| Amoxicillin (J01CA04) | 27 | 1.3 |
| Penicillin v (J01 CE08) | 79 | 3.9 |
| Combination with β-lactamase inhibitor | 163 | 57.6 |
| Amoxicillin and clavulanic acid (J01CR02) | 114 | 5.6 |
| Piperacillin + tazobactam (J01CR05) | 49 | 2.4 |
| Cephalosporins | 933 | 46.1 |
| 1st generation | 114 | 12.2 |
| Cephalexin (J01DB01) | 31 | 0.2 |
| Cefazolin (J01DB04) | 86 | 4.3 |
| Cephradine (J01DB09) | 25 | 1.3 |
| 2nd generation | 83 | 8.9 |
| Cefuroxime (J01 DC02) | 72 | 3.6 |
| Cefaclor (J01 DC04) | 11 | 0.5 |
| 3rd generation | 729 | 78.1 |
| Cefotaxime (J01DD01) | 23 | 1.4 |
| Ceftazidime (J01DD02) | 20 | 0.9 |
| Ceftriaxone (J01DD04) | 423 | 21 |
| Cefixime (J01DD08) | 32 | 1.6 |
| Cefoperazone and salbactum (J01DD62) | 231 | 11.4 |
| 4th generation | 7 | 0.80 |
| Cefepime (J01DE01) | 7 | 0.3 |
| Carbapenems | 31 | 1.5 |
| Imipenem (J01DH51) | 9 | 0.4 |
| Meropenem (J01DH02) | 22 | 1 |
| Macrolides | 59 | 2.9 |
| Erythromycin (J01FA01) | 4 | 0.2 |
| Clarithromycin (J01FA09) | 48 | 2.4 |
| Azithromycin (J01FA10) | 7 | 0.3 |
| Aminoglycosides | 315 | 15.6 |
| Gentamicin (J01GB03) | 8 | 0.4 |
| Amikacin (J01GB06) | 307 | 15.2 |
| Fluoroquinolones | 193 | 9.5 |
| Ciprofloxacin (J01MA02) | 130 | 6.4 |
| Levofloxacin (J01MA12) | 17 | 0.8 |
| Moxifloxacin (J01MA14) | 41 | 2 |
| Ofloxacin (J01MA01) | 3 | 0.1 |
| Norfloxacin (J01MA06) | 2 | 0.09 |
| Others Antibacterials | 208 | 10.4 |
| Vancomycin (J01XA01) | 80 | 4.0 |
| Metronidazole (J01XD01) | 119 | 5.9 |
| Linezolid (J01XX08) | 9 | 0.5 |